The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes : a phase-III intergroup study

One hundred and forty one patients were treated in a combined Eastern Cooperative Oncology Group and Southwest Oncology Group phase-III study evaluating low-dose cytarabine (LDAC) versus supportive therapy for the treatment of myelodysplastic syndrome (MDS). Patients were randomized to either cytara...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 1992-10, Vol.65 (4), p.162-168
Hauptverfasser:	MILLER, K. B, KYUNGMANN, K, MORRISON, F. S, WINTER, J. N, BENNETT, J. M, NEIMAN, R. S, HEAD, D. R, CASSILETH, P. A, O'CONNELL, M. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anemia, Refractory, with Excess of Blasts - drug therapy Antineoplastic agents Biological and medical sciences Blood Transfusion Chemotherapy Cytarabine - administration & dosage Cytarabine - adverse effects Cytarabine - therapeutic use Female Humans Male Medical sciences Middle Aged Myelodysplastic Syndromes - drug therapy Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!